Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») located in Nantes, North-West of France and specialized in high-quality preclinical evaluation services in the field of bone and joint diseases and more particularly in bone diseases from tumor origin.
Atlantic Bone Screen stems from LPRO laboratory « Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives » UMR 957 of the Medecine Faculty of Nantes and relies on its recognized expertise developed in the field of bone diseases.
Created in 2005 by Ronan LE BOT, CEO of the company, Atlantic Bone Screen puts at your disposal a unique preclinical platform with a wide range of competitive in vitro and in vivo assays as well as histology and imaging services.
More than 110 preclinical studies have been run in Atlantic Bone Screen since the creation of the company in 2005.
Research centres from the most important pharmaceutical, food industry and biomaterial companies trust Atlantic Bone Screen.
Our Missions
Atlantic Bone Screen aims at optimizing and accelerating the development of your compounds, giving you therefore the possibility to identify and characterize the therapeutic potential of your drug candidates, nutraceuticals and biomaterials.
Our Values
Quality Management
Atlantic Bone Screen ISO 9001:2008 certificate
Our priority : Your full satisfaction with personalized solutions coming up to high requirements in terms of quality and confidentiality.
Atlantic Bone Screen commits itself to providing you with tailor-made preclinical studies and a high-quality expertise within the best timelines. All our studies are carried out according to a protocol study you validate before its implementation. Besides we respect ISO 9001v2008 requirements and apply Good Laboratory Practices (GLP). We plan on proposing GLP-compliant studies by 2012.
Besides, Atlantic Bone Screen ensures an entire confidentiality on each conducted project (access exclusively reserved to Atlantic Bone Screen employees, specific codification for each project, performance of all the protocols in-house, setting up of confidentiality agreements).
All Atlantic Bone Screen technicians involved present a nominative registered license. In vivo assays are performed according to specific procedures in registered animal facilities complying with current regulations.
Reactivity
Our objective : A flexible and available team within an organization based on strong reactivity at your disposal.
Building a real collaboration with you. Our team will be yours and will think ahead your needs in terms of Research and Development in order for you to easily reach your scientific targets. We commit ourselves to providing you with a precise and quick reply.
The organization of Atlantic Bone Screen guarantees all the criteria required for preclinical studies implementation: adaptability, quality and reactivity.
Once your request is sent :
- Acknowledgement of receipt of your request
- Confidential code allocation
- Dedicated project manager allocation
- Protocol study and price quotation sent to the sponsor
- Communication with the project manager before final agreement
- Sending of the study plan
- Communication with the project manager before validation of the study plan
- Weekly follow-up of the study
- Sending of intermediate reports
- Organization of teleconferences
- Sending of the final report (with all the study generated data)
- Sending of the draft report
- Discussions
- Validation
- Sending of the final report in electronic and paper version.
Innovation
Our will : Constantly innovative services relying on the latest scientific breakthroughs and on the continuous development of new specific preclinical models.
Atlantic Bone Screen sets up personalized experimental protocols coming up to your scientific expectations thanks to a preclinical platform constantly sustained with in-house R&D projects. This platform enables us to validate and promote the compounds thanks to a wide range of relevant, groundbreaking and diversified in vitro and in vivo assays.
The company belongs to the network of biotechnology companies of Atlanpole Biotherapies cluster. Therefore Atlantic Bone Screen has many partners whom services are complementary. We thus have the chance to dispose of wide-ranging skills in the field of life sciences (www.atlanpolebiotherapies.com)
